CEN Biotech, Inc.

Equities

CENB.F

CA15130L1040

Market Closed - OTC Markets Other stock markets 12:50:25 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0031 ^USD	0.00%		0.00%	+3.33%

2023	CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer	CI
2022	CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI

CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 14, 2022 at 01:31 pm EST

CEN Biotech, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.135856 million compared to USD 0.272166 million a year ago. Net loss was USD 0.400227 million compared to USD 0.71894 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.
For the nine months, sales was USD 0.678333 million compared to USD 0.272166 million a year ago. Net loss was USD 1.03 million compared to USD 16.84 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.44 a year ago.

Latest news about CEN Biotech, Inc.

CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer	23-03-29	CI
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-22	CI
CEN Biotech, Inc. announced that it has received $0.07 million in funding from 1800 Diagonal Lending, LLC	22-05-23	CI
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-20	CI
CEN Biotech, Inc. Announces Changes to Its Board	22-04-21	CI
CEN Biotech, Inc. Announces Management Changes	22-04-19	CI
CEN Biotech, Inc. Announces Executive Changes	22-04-19	CI
CEN Biotech, Inc. Announces Executive Changes	22-04-19	CI
CEN Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-14	CI
CEN Biotech, Inc. Auditor Raises 'Going Concern' Doubt	22-04-13	CI
CEN Biotech, Inc. Announces Executive Changes	21-12-08	CI
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-19	CI
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
CEN Biotech, Inc. (OTCPK:CENB.F) completed the acquisition of Clear Com Media Inc. from Lawrence Lehoux, Kellie Coulter, Chelsea Lehoux, Joanne Lehoux and Joshua Lehoux.	21-07-08	CI
Cen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-12	CI
CEN Biotech, Inc. Announces Board Appointments	21-04-19	CI
CEN Biotech, Inc. (OTCPK:CENB.F) entered into a Share Exchange Agreement to acquire Clear Com Media Inc. from Lawrence Lehoux, Kellie Coulter, Chelsea Lehoux, Joanne Lehoux and Joshua Lehoux for $5 million.	21-04-19	CI
CEN Biotech, Inc. Appoints Bahige Chaaban as Chief Executive Officer	21-04-19	CI
Cen Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-12	CI
Cen Biotech, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-06	CI
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-07-31	CI
Cen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-12	CI
CEN Biotech, Inc. cancelled the acquisition of 70% of the outstanding common stock in the capital of AstralENERGY Solar Manufacturing Corporation, LTD.	20-05-18	CI
Cen Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-14	CI

Chart CEN Biotech, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company